Suppr超能文献

HPV-16、HPV-18 和 HPV-52 变体在意大利普通人群和高危人群中的遗传特征。

Genetic characterization of variants of HPV‑16, HPV‑18 and HPV‑52 circulating in Italy among general and high‑risk populations.

机构信息

Department of Biomedical Sciences for Health, University of Milan, I‑20133 Milan, Italy.

School of Medicinal and Health Products Sciences, University of Camerino, I‑62032 Camerino, Italy.

出版信息

Mol Med Rep. 2020 Feb;21(2):894-902. doi: 10.3892/mmr.2019.10847. Epub 2019 Nov 25.

Abstract

Viral factors, such as high‑risk human papillomavirus variants, can increase the risk of viral persistence and influence the progression to cancer. In the present study, the long control region (LCR) of human papillomavirus (HPV)‑16 and HPV‑52, and the L1 region of HPV‑16 and HPV‑18, identified from subjects belonging to both general and high‑risk populations (migrants, HIV+ subjects and adolescent/young people) residing in Italy, were characterized using molecular and phylogenetic techniques. To the best of our knowledge, this is the first Italian study to analyze a large number of sequences (n=458) and report phylogenetic data on the HPV‑52 variants. The phylogenetic analysis showed that 90% of the LCR variants of HPV‑16 and HPV‑52 clustered within lineage A (European lineage) and only sequences identified from subjects belonging to high‑risk populations fell into the non‑European lineages. Analysis of the LCRs revealed a high genomic diversity with a large number of changes. Several mutations in the binding sites for viral and cellular transcription factors characterized the HPV‑16 LCR variants belonging to the African lineages B and C, were observed in subjects with cytological abnormalities (high squamous intraepithelial lesions). The HPV‑16 and HPV‑18 L1 molecular characterization identified 30% of changes in the immune‑dominant epitope loops. These data give a clear picture of the situation in Italy, and a starting point for understanding the molecular pathogenesis and developing molecular diagnostics for HPV, vaccines and other therapeutic approaches in order to control and/or eliminate virus‑induced diseases.

摘要

病毒因素,如高危型人乳头瘤病毒(HPV)变异体,可增加病毒持续存在的风险,并影响癌症的进展。本研究采用分子和系统发育技术,对意大利普通人群和高危人群(移民、HIV+ 人群和青少年/年轻人)中 HPV-16 和 HPV-52 的长控制区(LCR)以及 HPV-16 和 HPV-18 的 L1 区进行了鉴定。据我们所知,这是意大利首次对大量序列(n=458)进行分析,并报告 HPV-52 变异体的系统发育数据。系统发育分析显示,90%的 HPV-16 和 HPV-52 的 LCR 变异体聚类在 A 谱系(欧洲谱系)内,只有来自高危人群的序列属于非欧洲谱系。对 LCR 的分析显示,其具有高度的基因组多样性和大量的变化。在细胞学异常(高级别鳞状上皮内病变)的患者中观察到 HPV-16 LCR 变异体属于 B 和 C 非洲谱系的病毒和细胞转录因子结合位点的多个突变。HPV-16 和 HPV-18 L1 分子特征鉴定出 30%的免疫显性表位环发生了变化。这些数据清楚地描述了意大利的情况,为理解 HPV 的分子发病机制以及开发分子诊断、疫苗和其他治疗方法以控制和/或消除病毒诱导的疾病提供了起点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验